Novo Nordisk’s Unprecedented Surge Signals Burning Demand for Weight‑Loss Drugs
Novo Nordisk’s record-breaking growth highlights ‘insatiable demand’ for weight loss drugs,There has been a big achievement’ for the Danish pharmaceutical company as revenue growth rate reaches 20 year high. Growth isn’t limited by demand, but by production capacity the market…
